Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

U.S. price hikes on branded drugs far outpace 2012 inflation
Reuters
Wednesday, November 28, 2012 - 10:35am
tags:
drug pricing
GSK and J&J lead rivals in drug access for poor
Reuters
Wednesday, November 28, 2012 - 10:18am
tags:
JNJ, GSK
AstraZeneca, Pfizer partner on $100M drug research collaboration project
Fierce Biotech
Tuesday, November 27, 2012 - 1:29pm
tags:
R&D, Pfizer, AstraZeneca
Merck and Endocyte say EU is reviewing vintafolide as a treatment for ovarian cancer
Yahoo/AP
Tuesday, November 27, 2012 - 1:08pm
tags:
Merck, Endocyte, Europe, vintafolide, ovarian cancer
Transcept, partner launch $29M ad campaign around sleep drug Intermezzo
bizjournals.com
Tuesday, November 27, 2012 - 11:21am
tags:
Transcept, Intermezzo, drug ads, insomnia, Purdue Pharma
Abbott nabs new Humira use, launches Amitiza in Japan
Fierce Pharma
Tuesday, November 27, 2012 - 11:18am
tags:
Humira, Amitiza, Japan, Abbott Labs, AbbVie
Regeneron says Eylea approved in European Union
Yahoo/AP
Tuesday, November 27, 2012 - 11:17am
tags:
Eylea, Europe, Regeneron
Acadia climbs as company says pimavanserin reduced psychosis in Parkinson's disease patients
Yahoo/AP
Tuesday, November 27, 2012 - 11:16am
tags:
Acadia, Parkinson's Disease, pimavanserin, Parkinson's Disease Psychosis
Vivus Initiates Free Trial - May Boost Sales
Seeking Alpha
Tuesday, November 27, 2012 - 11:15am
tags:
Vivus, Qsymia
10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook
TheStreet.com
Tuesday, November 27, 2012 - 11:12am
tags:
Affymax, Pharmacyclics, Galena Biopharma, Threshold Pharmaceuticals, Hemispherx Biopharma, Sunesis, Celsion, Sarepta, Arena Pharmaceuticals, BioDelivery Sciences
Exelixis Traders Brace For Upcoming FDA Decision
Seeking Alpha
Tuesday, November 27, 2012 - 11:10am
tags:
FDA, Exelixis, medullary thyroid cancer, cabozantinib
Novo Nordisk says new data show Victoza advantage
Reuters
Tuesday, November 27, 2012 - 10:36am
tags:
diabetes, Novo Nordisk, Victoza, Merck, Amylin
Fat Chance: The Vivus Diet Pill Has Skinny Sales
Pharmalot
Tuesday, November 27, 2012 - 10:33am
tags:
Vivus, obesity, Qsymia
Massachusetts Weakens Gift Ban For Doctors
Pharmalot
Tuesday, November 27, 2012 - 10:32am
tags:
physicians, physician gifts, Massachusetts
Theravance’s Vibativ May Have Risk for Pneumonia Patients
Bloomberg
Tuesday, November 27, 2012 - 10:31am
tags:
Vibativ, pneumonia, Theravance
Gilead Sciences Scores First Win With Late-Stage Hep C Study
TheStreet.com
Tuesday, November 27, 2012 - 10:30am
tags:
hepatitis C, Gilead, sofosbuvir
Investing in a better flu shot
Markewatch
Tuesday, November 27, 2012 - 10:29am
tags:
vaccines, Flu, GSK, AstraZeneca, Sanofi
Merck KGaA to resist lure of potential proceeds from OTC sale
Reuters
Tuesday, November 27, 2012 - 10:27am
tags:
OTC, M&A, Merck KGaA, Schiff
Abbot’s Spin-Off Abbvie: A Step in the Right Direction
Motley Fool
Tuesday, November 27, 2012 - 10:25am
tags:
AbbVie, Abbott Labs
J&J preps case for quick FDA approval of new TB drug
Fierce Biotech
Monday, November 26, 2012 - 12:21pm
tags:
JNJ, FDA, tuberculosis, bedaquiline

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.